University of Groningen
Cerebral Metabolic Patterns In Neurodegeneration
Meles, Sanne
DOI:
10.33612/diss.118683600
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Meles, S. (2020). Cerebral Metabolic Patterns In Neurodegeneration. Rijksuniversiteit Groningen.
https://doi.org/10.33612/diss.118683600
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
References
Aarsland, D., Bronnick, K. & Fladby, T. 2011, “Mild cognitive impairment in Parkinson’s disease”, Current
neurology and neuroscience reports, vol. 11, no. 4, pp. 371-378.
Aarsland, D., Larsen, J.P., Karlsen, K., Lim, N.G. & Tandberg, E. 1999, “Mental symptoms in Parkinson’s disease are important contributors to caregiver distress”, International journal of geriatric psychiatry, vol. 14, no. 10, pp. 866-874.
Aarsland, D., Larsen, J.P., Tandberg, E. & Laake, K. 2000, “Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study”, Journal of the American Geriatrics Society, vol. 48, no. 8, pp. 938-942.
Adler, C.H., Beach, T.G., Hentz, J.G., Shill, H.A., Caviness, J.N., Driver-Dunckley, E., Sabbagh, M.N., Sue, L.I., Jacobson, S.A., Belden, C.M. & Dugger, B.N. 2014, “Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study”, Neurology, vol. 83, no. 5, pp. 406-412.
Akaike, H. 1974, “A new look at the statistical model identification.”, IEEE Trans. Automat. Contr, no. 19, pp. 716-23.
Alavi, A. & Reivich, M. 2002, “Guest editorial: the conception of FDG-PET imaging”, Seminars in nuclear
medicine, vol. 32, no. 1, pp. 2-5.
Albin, R.L., Koeppe, R.A., Bohnen, N.I., Wernette, K., Kilbourn, M.A. & Frey, K.A. 2008, “Spared caudal brainstem SERT binding in early Parkinson’s disease”, Journal of cerebral blood flow and metabolism, vol. 28, no. 3, pp. 441-444.
Albin, R.L., Young, A.B. & Penney, J.B. 1989, “The functional anatomy of basal ganglia disorders”, Trends in
neurosciences, vol. 12, no. 10, pp. 366-375.
Alexander, G.E., DeLong, M.R. & Strick, P.L. 1986, “Parallel organization of functionally segregated circuits linking basal ganglia and cortex”, Annual Review of Neuroscience, vol. 9, pp. 357-381.
Alvarez, J.A. & Emory, E. 2006, “Executive function and the frontal lobes: a meta-analytic review”,
Neuropsychology review, vol. 16, no. 1, pp. 17-42.
Andersson, J.L.R., Jenkinson, M. & Smith, S. 2007, “Non-linear registration aka Spatial normalization”. FMRIB
Technial Report.
Antonini, A., Leenders, K.L., Vontobel, P., Maguire, R.P., Missimer, J., Psylla, M. & Gunther, I. 1997, “Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson’s disease”, Brain, vol. 120 ( Pt 12), no. Pt 12, pp. 2187-2195.
Arlot, S. & Celisse, A. 2010, “A survey of cross-validation procedures for model selection”, Statistics Surveys, vol. 4, pp. 40–79.
Arnaldi, D., De Carli, F., Picco, A., Ferrara, M., Accardo, J., Bossert, I., Fama, F., Girtler, N., Morbelli, S., Sambuceti, G. & Nobili, F. 2015a, “Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?”, Neurobiology of aging, vol. 36, no. 12, pp. 3300-3305.
Arnaldi, D., Fama, F., De Carli, F., Morbelli, S., Ferrara, M., Picco, A., Accardo, J., Primavera, A., Sambuceti, G. & Nobili, F. 2015b, “The Role of the Serotonergic System in REM Sleep Behavior Disorder”, Sleep, vol. 38, no. 9, pp. 1505-1509.
Arnaldi, D., Morbelli, S., Brugnolo, A., Girtler, N., Picco, A., Ferrara, M., Accardo, J., Buschiazzo, A., de Carli, F., Pagani, M. & Nobili, F. 2016, “Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson’s disease and probable RBD”, Parkinsonism & related disorders, vol. 29, pp. 47-53. Artzi, M., Even-Sapir, E., Lerman Shacham, H., Thaler, A., Urterger, A.O., Bressman, S., Marder, K., Hendler, T.,
Giladi, N., Ben Bashat, D. & Mirelman, A. 2017, “DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers”, PloS one, vol. 12, no. 4, pp. e0175424. Asanuma, K., Tang, C., Ma, Y., Dhawan, V., Mattis, P., Edwards, C., Kaplitt, M.G., Feigin, A. & Eidelberg, D.
2006, “Network modulation in the treatment of Parkinson’s disease”, Brain, vol. 129, no. Pt 10, pp. 2667-2678.
Ashburner, J. 2007, “A fast diffeomorphic image registration algorithm”, NeuroImage, vol. 38, no. 1, pp. 95-113. Ashburner, J. & Friston, K.J. 2000, “Voxel-based morphometry - the methods”, NeuroImage, vol. 11, no. 6 Pt 1,
pp. 805-821.
Attwell, D. & Iadecola, C. 2002, “The neural basis of functional brain imaging signals”, Trends in neurosciences, vol. 25, no. 12, pp. 621-625.
Attwell, D. & Laughlin, S.B. 2001, “An energy budget for signaling in the grey matter of the brain”, Journal of
cerebral blood flow and metabolism, vol. 21, no. 10, pp. 1133-1145.
Barber, T.R., Klein, J.C., Mackay, C.E. & Hu, M.T.M. 2017, “Neuroimaging in pre-motor Parkinson’s disease”,
NeuroImage.Clinical, vol. 15, pp. 215-227.
Batipps, M., Miyaoka, M., Shinohara, M., Sokoloff, L. & Kennedy, C. 1981, “Comparative rates of local cerebral glucose utilization in the visual system of conscious albino and pigmented rats”, Neurology, vol. 31, no. 1, pp. 58-62.
Bauckneht, M., Chincarini, A., De Carli, F., Terzaghi, M., Morbelli, S., Nobili, F. & Arnaldi, D. 2018, “Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis”, Sleep medicine reviews, vol. 41, pp. 266-274.
Benarroch, E.E. 2013, “Pedunculopontine nucleus: functional organization and clinical implications”, Neurology, vol. 80, no. 12, pp. 1148-1155.
Berg, D., Postuma, R.B., Adler, C.H., Bloem, B.R., Chan, P., Dubois, B., Gasser, T., Goetz, C.G., Halliday, G., Joseph, L., Lang, A.E., Liepelt-Scarfone, I., Litvan, I., Marek, K., Obeso, J., Oertel, W., Olanow, C.W., Poewe, W., Stern, M. & Deuschl, G. 2015, “MDS research criteria for prodromal Parkinson’s disease”,
Movement disorders, vol. 30, no. 12, pp. 1600-1611.
Berg, D., Seppi, K., Behnke, S., Liepelt, I., Schweitzer, K., Stockner, H., Wollenweber, F., Gaenslen, A., Mahlknecht, P., Spiegel, J., Godau, J., Huber, H., Srulijes, K., Kiechl, S., Bentele, M., Gasperi, A., Schubert, T., Hiry, T., Probst, M., Schneider, V., Klenk, J., Sawires, M., Willeit, J., Maetzler, W.,
Fassbender, K., Gasser, T. & Poewe, W. 2011, “Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons”, Archives of Neurology, vol. 68, no. 7, pp. 932-937.
Berti, V., Polito, C., Ramat, S., Vanzi, E., De Cristofaro, M.T., Pellicano, G., Mungai, F., Marini, P., Formiconi, A.R., Sorbi, S. & Pupi, A. 2010, “Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson’s disease”, European journal of nuclear medicine and molecular imaging, vol. 37, no. 3, pp. 537-544.
Blakemore, S.J. & Sirigu, A. 2003, “Action prediction in the cerebellum and in the parietal lobe”, Experimental
brain research, vol. 153, no. 2, pp. 239-245.
Boeve, B.F. 2013, “Idiopathic REM sleep behaviour disorder in the development of Parkinson’s disease”, Lancet
neurology, vol. 12, no. 5, pp. 469-482.
Boeve, B.F. 2010, “REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions”,
Annals of the New York Academy of Sciences, vol. 1184, pp. 15-54.
Boeve, B.F. & Kantarci, K. 2018, “Multimodal imaging in RBD - present and future”, Nature reviews Neurology, vol. 14, no. 10, pp. 574-576.
Boeve, B.F., Molano, J.R., Ferman, T.J., Smith, G.E., Lin, S.C., Bieniek, K., Haidar, W., Tippmann-Peikert, M., Knopman, D.S., Graff-Radford, N.R., Lucas, J.A., Petersen, R.C. & Silber, M.H. 2011, “Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort”,
Sleep medicine, vol. 12, no. 5, pp. 445-453.
Bohnen, N.I. & Frey, K.A. 2014, “Parkinson Dementia: PET findings” in PET and SPECT in Neurology, eds. R.A. Dierckx, A. Otte, de Vries E.F.J., A. van Waarde & K.L. Leenders, first edn, Springer, Verlag Berlin Heidelberg, pp. 359.
Bohnen, N.I. & Albin, R.L. 2011, “The cholinergic system and Parkinson disease”, Behavioural brain research, vol. 221, no. 2, pp. 564-573.
Bohnen, N.I., Koeppe, R.A., Minoshima, S., Giordani, B., Albin, R.L., Frey, K.A. & Kuhl, D.E. 2011, “Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study”, Journal of
nuclear medicine, vol. 52, no. 6, pp. 848-855.
Booij, J., Teune, L.K. & Verberne, H.J. 2012, “The role of molecular imaging in the differential diagnosis of parkinsonism”, The quarterly journal of nuclear medicine and molecular imaging, vol. 56, no. 1, pp. 17-26. Borghammer, P., Chakravarty, M., Jonsdottir, K.Y., Sato, N., Matsuda, H., Ito, K., Arahata, Y., Kato, T. & Gjedde,
A. 2010, “Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages”, Brain structure & function, vol. 214, no. 4, pp. 303-317.
Borghammer, P., Cumming, P., Aanerud, J. & Gjedde, A. 2009, “Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson’s disease”, NeuroImage, vol. 45, no. 2, pp. 249-257.
Borghammer, P., Jonsdottir, K.Y., Cumming, P., Ostergaard, K., Vang, K., Ashkanian, M., Vafaee, M., Iversen, P. & Gjedde, A. 2008, “Normalization in PET group comparison studies--the importance of a valid reference region”, NeuroImage, vol. 40, no. 2, pp. 529-540.
Bostan, A.C., Dum, R.P. & Strick, P.L. 2013, “Cerebellar networks with the cerebral cortex and basal ganglia”,
Trends in cognitive sciences, vol. 17, no. 5, pp. 241-254.
Braak, H., Del Tredici, K., Rub, U., de Vos, R.A., Jansen Steur, E.N. & Braak, E. 2003, “Staging of brain pathology related to sporadic Parkinson’s disease”, Neurobiology of aging, vol. 24, no. 2, pp. 197-211. Braga-Neto, P., Dutra, L.A., Pedroso, J.L. & Barsottini, O.G. 2014, “Cognitive dysfunction in spinocerebellar
ataxia type 3: variable topographies and patterns”, Movement disorders, vol. 29, no. 1, pp. 156-157. Braga-Neto, P., Dutra, L.A., Pedroso, J.L., Felicio, A.C., Alessi, H., Santos-Galduroz, R.F., Bertolucci, P.H.,
Castiglioni, M.L., Bressan, R.A., de Garrido, G.E., Barsottini, O.G. & Jackowski, A. 2012a, “Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas”, Cerebellum, vol. 11, no. 4, pp. 1037-1044.
Braga-Neto, P., Felicio, A.C., Hoexter, M.Q., Pedroso, J.L., Dutra, L.A., Alessi, H., Minett, T., Santos-Galduroz, R.F., da Rocha, A.J., Garcia, L.A., Bertolucci, P.H., Bressan, R.A. & Barsottini, O.G. 2012b, “Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study”, Parkinsonism & related
disorders, vol. 18, no. 7, pp. 854-858.
Brajkovic, L., Kostic, V., Sobic-Saranovic, D., Stefanova, E., Jecmenica-Lukic, M., Jesic, A., Stojiljkovic, M., Odalovic, S., Gallivanone, F., Castiglioni, I., Radovic, B., Trajkovic, G. & Artiko, V. 2017, “The utility of FDG-PET in the differential diagnosis of Parkinsonism”, Neurological research, vol. 39, no. 8, pp. 675-684. Brigo, F., Turri, G. & Tinazzi, M. 2015, “123I-FP-CIT SPECT in the differential diagnosis between dementia
with Lewy bodies and other dementias”, Journal of the neurological sciences, vol. 359, no. 1-2, pp. 161-171. Brittain, J.S. & Brown, P. 2014, “Oscillations and the basal ganglia: motor control and beyond”, NeuroImage, vol.
85 Pt 2, pp. 637-647.
Brooks, D.J. 2016, “Molecular imaging of dopamine transporters”, Ageing research reviews, vol. 30, pp. 114-121. Brooks, D.J. 2007, “Imaging non-dopaminergic function in Parkinson’s disease”, Molecular imaging and biology,
vol. 9, no. 4, pp. 217-222.
Brooks, D.J., Ibanez, V., Sawle, G.V., Playford, E.D., Quinn, N., Mathias, C.J., Lees, A.J., Marsden, C.D., Bannister, R. & Frackowiak, R.S. 1992, “Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography”, Annals of Neurology, vol. 31, no. 2, pp. 184-192.
Brooks, D.J., Seppi, K. & Neuroimaging Working Group on MSA 2009, “Proposed neuroimaging criteria for the diagnosis of multiple system atrophy”, Movement disorders, vol. 24, no. 7, pp. 949-964.
Buter, T.C., van den Hout, A., Matthews, F.E., Larsen, J.P., Brayne, C. & Aarsland, D. 2008, “Dementia and survival in Parkinson disease: a 12-year population study”, Neurology, vol. 70, no. 13, pp. 1017-1022. Buzsaki, G., Kaila, K. & Raichle, M. 2007, “Inhibition and brain work”, Neuron, vol. 56, no. 5, pp. 771-783. Buzsaki, G., Logothetis, N. & Singer, W. 2013, “Scaling brain size, keeping timing: evolutionary preservation of
brain rhythms”, Neuron, vol. 80, no. 3, pp. 751-764.
Carbon, M., Ma, Y., Barnes, A., Dhawan, V., Chaly, T., Ghilardi, M.F. & Eidelberg, D. 2004, “Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism”, NeuroImage, vol. 21, no. 4, pp. 1497-1507.
Carbon, M., Reetz, K., Ghilardi, M.F., Dhawan, V. & Eidelberg, D. 2010, “Early Parkinson’s disease: longitudinal changes in brain activity during sequence learning”, Neurobiology of disease, vol. 37, no. 2, pp. 455-460. Caselli, R.J., Chen, K., Bandy, D., Smilovici, O., Boeve, B.F., Osborne, D., Alexander, G.E., Parish, J.M., Krahn,
L.E. & Reiman, E.M. 2006, “A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior”, Sleep, vol. 29, no. 7, pp. 927-933.
Cerami, C., Della Rosa, P.A., Magnani, G., Santangelo, R., Marcone, A., Cappa, S.F. & Perani, D. 2014, “Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia”,
NeuroImage.Clinical, vol. 7, pp. 187-194.
Cherry, S.R., Sorenson, J.A. & Phelps, M.A. 2012, Physics in Nuclear Medicine, fourth edn, Elsevier Saunders, Philadelphia.
Cilia, R., Marotta, G., Benti, R., Pezzoli, G. & Antonini, A. 2005, “Brain SPECT imaging in multiple system atrophy”, Journal of neural transmission, vol. 112, no. 12, pp. 1635-1645.
Cochrane, C.J. & Ebmeier, K.P. 2013, “Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis”, Neurology, vol. 80, no. 9, pp. 857-864.
Cohen, O.S., Vakil, E., Tanne, D., Molshatzki, N., Nitsan, Z. & Hassin-Baer, S. 2012, “The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease”, Journal of
geriatric psychiatry and neurology, vol. 25, no. 2, pp. 71-77.
Culebras, A. & Moore, J.T. 1989, “Magnetic resonance findings in REM sleep behavior disorder”, Neurology, vol. 39, no. 11, pp. 1519-1523.
Dang-Vu, T.T., Gagnon, J.F., Vendette, M., Soucy, J.P., Postuma, R.B. & Montplaisir, J. 2012, “Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder”, Neurology, vol. 79, no. 24, pp. 2302-2306.
Dayan, E. & Browner, N. 2017, “Alterations in striato-thalamo-pallidal intrinsic functional connectivity as a prodrome of Parkinson’s disease”, NeuroImage.Clinical, vol. 16, pp. 313-318.
De Marzi, R., Seppi, K., Hogl, B., Muller, C., Scherfler, C., Stefani, A., Iranzo, A., Tolosa, E., Santamaria, J., Gizewski, E., Schocke, M., Skalla, E., Kremser, C. & Poewe, W. 2016, “Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder”, Annals of Neurology, vol. 79, no. 6, pp. 1026-1030.
Debette, S. & Markus, H.S. 2010, “The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis”, BMJ (Clinical research ed.), vol. 341, pp. c3666. Delaville, C., Deurwaerdere, P.D. & Benazzouz, A. 2011, “Noradrenaline and Parkinson’s disease”, Frontiers in
systems neuroscience, vol. 5, pp. 31.
Della Rosa, P.A., Cerami, C., Gallivanone, F., Prestia, A., Caroli, A., Castiglioni, I., Gilardi, M.C., Frisoni, G., Friston, K., Ashburner, J., Perani, D. & EADC-PET Consortium 2014, “A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia”, Neuroinformatics, vol. 12, no. 4, pp. 575-593.
DeLong, M.R. & Wichmann, T. 2007, “Circuits and circuit disorders of the basal ganglia”, Archives of Neurology, vol. 64, no. 1, pp. 20-24.
Dhawan, V., Tang, C.C., Ma, Y., Spetsieris, P. & Eidelberg, D. 2012, “Abnormal network topographies and changes in global activity: absence of a causal relationship”, NeuroImage, vol. 63, no. 4, pp. 1827-1832. Doppler, K., Jentschke, H.M., Schulmeyer, L., Vadasz, D., Janzen, A., Luster, M., Hoffken, H., Mayer, G.,
Brumberg, J., Booij, J., Musacchio, T., Klebe, S., Sittig-Wiegand, E., Volkmann, J., Sommer, C. & Oertel, W.H. 2017, “Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease”, Acta Neuropathologica, vol. 133, no. 4, pp. 535-545.
Duarte Folle, A., Paul, K.C., Bronstein, J.M., Keener, A.M. & Ritz, B. 2019, “Clinical progression in Parkinson’s disease with features of REM sleep behavior disorder: A population-based longitudinal study”, Parkinsonism
& related disorders, vol 62, pp.105-111.
Dubois, B., Feldman, H.H., Jacova, C., Hampel, H., Molinuevo, J.L., Blennow, K., DeKosky, S.T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G.B., Fox, N.C., Galasko, D., Habert, M.O., Jicha, G.A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L.C., Vellas, B., Visser, P.J., Schneider, L., Stern, Y., Scheltens, P. & Cummings, J.L. 2014, “Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria”,
The Lancet.Neurology, vol. 13, no. 6, pp. 614-629.
Dubois, B., Slachevsky, A., Litvan, I. & Pillon, B. 2000, “The FAB: a Frontal Assessment Battery at bedside”,
Neurology, vol. 55, no. 11, pp. 1621-1626.
Dwamena, B.A., Zempel, S., Klopper, J.F., Van Heerden, B., Wieland, D. & Shapiro, B. 1998, “Brain uptake of iodine-131 metaiodobenzylguanidine following therapy of malignant pheochromocytoma”, Clinical nuclear
medicine, vol. 23, no. 7, pp. 441-445.
Eckert, T., Barnes, A., Dhawan, V., Frucht, S., Gordon, M.F., Feigin, A.S. & Eidelberg, D. 2005, “FDG PET in the differential diagnosis of parkinsonian disorders”, NeuroImage, vol. 26, no. 3, pp. 912-921.
Ehrminger, M., Latimier, A., Pyatigorskaya, N., Garcia-Lorenzo, D., Leu-Semenescu, S., Vidailhet, M., Lehericy, S. & Arnulf, I. 2016, “The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder”, Brain, vol. 139, no. Pt 4, pp. 1180-1188.
Ehrt, U., Broich, K., Larsen, J.P., Ballard, C. & Aarsland, D. 2010, “Use of drugs with anticholinergic effect and impact on cognition in Parkinson’s disease: a cohort study”, Journal of neurology, neurosurgery, and
psychiatry, vol. 81, no. 2, pp. 160-165.
Eidelberg, D. 2009, “Metabolic brain networks in neurodegenerative disorders: a functional imaging approach”,
Trends in neurosciences, vol. 32, no. 10, pp. 548-557.
Eidelberg, D., Moeller, J.R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D. & Przedborski, S. 1994, “The metabolic topography of parkinsonism”, Journal of cerebral
blood flow and metabolism, vol. 14, no. 5, pp. 783-801.
Eidelberg, D., Moeller, J.R., Kazumata, K., Antonini, A., Sterio, D., Dhawan, V., Spetsieris, P., Alterman, R., Kelly, P.J., Dogali, M., Fazzini, E. & Beric, A. 1997, “Metabolic correlates of pallidal neuronal activity in Parkinson’s disease”, Brain, vol. 120 ( Pt 8), no. Pt 8, pp. 1315-1324.
Eisensehr, I., Linke, R., Noachtar, S., Schwarz, J., Gildehaus, F.J. & Tatsch, K. 2000, “Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson’s disease and controls”, Brain, vol. 123 ( Pt 6), no. Pt 6, pp. 1155-1160.
Eisensehr, I., Linke, R., Tatsch, K., Kharraz, B., Gildehaus, J.F., Wetter, C.T., Trenkwalder, C., Schwarz, J. & Noachtar, S. 2003, “Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls”, Sleep, vol. 26, no. 5, pp. 507-512.
Ellmore, T.M., Castriotta, R.J., Hendley, K.L., Aalbers, B.M., Furr-Stimming, E., Hood, A.J., Suescun, J., Beurlot, M.R., Hendley, R.T. & Schiess, M.C. 2013, “Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder”, Sleep, vol. 36, no. 12, pp. 1885-1892.
Ellmore, T.M., Hood, A.J., Castriotta, R.J., Stimming, E.F., Bick, R.J. & Schiess, M.C. 2010, “Reduced volume of the putamen in REM sleep behavior disorder patients”, Parkinsonism & related disorders, vol. 16, no. 10, pp. 645-649.
Eshuis, S.A., Jager, P.L., Maguire, R.P., Jonkman, S., Dierckx, R.A. & Leenders, K.L. 2009, “Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls”, European
journal of nuclear medicine and molecular imaging, vol. 36, no. 3, pp. 454-462.
Farde, L., Ehrin, E., Eriksson, L., Greitz, T., Hall, H., Hedstrom, C.G., Litton, J.E. & Sedvall, G. 1985, “Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography”, Proceedings of the National Academy of Sciences of the United States of
America, vol. 82, no. 11, pp. 3863-3867.
Fereshtehnejad, S.M. & Postuma, R.B. 2017, “Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression?”, Current neurology and neuroscience reports, vol. 17, no. 4, pp. 34.
Fischl, B. 2012, “FreeSurfer”, NeuroImage, vol. 62, no. 2, pp. 774-781.
Fornito, A., Zalesky, A. & Bullmore, E. 2016, Fundamentals of Brain Network Analysis, 1st edn, Elsevier. Fox, M.D. & Raichle, M.E. 2007, “Spontaneous fluctuations in brain activity observed with functional magnetic
resonance imaging”, Nature reviews.Neuroscience, vol. 8, no. 9, pp. 700-711.
Fox, P.T., Mintun, M.A., Raichle, M.E. & Herscovitch, P. 1984, “A noninvasive approach to quantitative functional brain mapping with H2 (15)O and positron emission tomography”, Journal of cerebral blood flow
and metabolism, vol. 4, no. 3, pp. 329-333.
Fox, P.T. & Raichle, M.E. 1986, “Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects”, Proceedings of the National Academy of Sciences of the
United States of America, vol. 83, no. 4, pp. 1140-1144.
Fox, P.T., Raichle, M.E., Mintun, M.A. & Dence, C. 1988, “Nonoxidative glucose consumption during focal physiologic neural activity”, Science (New York, N.Y.), vol. 241, no. 4864, pp. 462-464.
Fraigne, J.J., Torontali, Z.A., Snow, M.B. & Peever, J.H. 2015, “REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology”, Frontiers in neurology, vol. 6, pp. 123.
Frauscher, B., Jennum, P., Ju, Y.E., Postuma, R.B., Arnulf, I., Cochen De Cock, V., Dauvilliers, Y., Fantini, M.L., Ferini-Strambi, L., Gabelia, D., Iranzo, A., Leu-Semenescu, S., Mitterling, T., Miyamoto, M., Miyamoto, T., Montplaisir, J.Y., Oertel, W., Pelletier, A., Prunetti, P., Puligheddu, M., Santamaria, J., Sonka, K., Unger, M., Wolfson, C., Zucconi, M., Terzaghi, M., Hogl, B., Mayer, G. & Manni, R. 2014, “Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study”,
Friston, K.J. 2011, “Functional and effective connectivity: a review”, Brain connectivity, vol. 1, no. 1, pp. 13-36. Frosini, D., Cosottini, M., Donatelli, G., Costagli, M., Biagi, L., Pacchetti, C., Terzaghi, M., Cortelli, P., Arnaldi,
D., Bonanni, E., Tosetti, M., Bonuccelli, U. & Ceravolo, R. 2017, “Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder”, Parkinsonism & related disorders, vol. 43, pp. 105-109.
Fujishiro, H., Iseki, E., Kasanuki, K., Chiba, Y., Ota, K., Murayama, N. & Sato, K. 2013, “A follow up study of non-demented patients with primary visual cortical hypometabolism: prodromal dementia with Lewy bodies”, Journal of the neurological sciences, vol. 334, no. 1-2, pp. 48-54.
Fujishiro, H., Iseki, E., Murayama, N., Yamamoto, R., Higashi, S., Kasanuki, K., Suzuki, M., Arai, H. & Sato, K. 2010, “Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?”, Psychogeriatrics, vol. 10, no. 3, pp. 144-152. Fujishiro, H., Nakamura, S., Kitazawa, M., Sato, K. & Iseki, E. 2012, “Early detection of dementia with Lewy
bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy”,
Journal of the neurological sciences, vol. 315, no. 1-2, pp. 115-119.
Gagnon, J.F., Postuma, R.B., Joncas, S., Desjardins, C. & Latreille, V. 2010, “The Montreal Cognitive Assessment: a screening tool for mild cognitive impairment in REM sleep behavior disorder”, Movement disorders, vol. 25, no. 7, pp. 936-940.
Gallea, C., Ewenczyk, C., Degos, B., Welter, M.L., Grabli, D., Leu-Semenescu, S., Valabregue, R., Berroir, P., Yahia-Cherif, L., Bertasi, E., Fernandez-Vidal, S., Bardinet, E., Roze, E., Benali, H., Poupon, C., Francois, C., Arnulf, I., Lehericy, S. & Vidailhet, M. 2017, “Pedunculopontine network dysfunction in Parkinson’s disease with postural control and sleep disorders”, Movement disorders, vol. 32, no. 5, pp. 693-704. Garcia-Garcia, D., Clavero, P., Gasca Salas, C., Lamet, I., Arbizu, J., Gonzalez-Redondo, R., Obeso, J.A. &
Rodriguez-Oroz, M.C. 2012, “Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease”, European journal of nuclear medicine and molecular
imaging, vol. 39, no. 11, pp. 1767-1777.
Garibotto, V., Borroni, B., Kalbe, E., Herholz, K., Salmon, E., Holtoff, V., Sorbi, S., Cappa, S.F., Padovani, A., Fazio, F. & Perani, D. 2008, “Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence”, Neurology, vol. 71, no. 17, pp. 1342-1349.
Garibotto, V., Herholz, K., Boccardi, M., Picco, A., Varrone, A., Nordberg, A., Nobili, F., Ratib, O. & Geneva Task Force for the Roadmap of Alzheimer’s Biomarkers 2017, “Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer’s disease in the context of a structured 5-phase development framework”, Neurobiology of aging, vol. 52, pp. 183-195.
Garraux, G., Phillips, C., Schrouff, J., Kreisler, A., Lemaire, C., Degueldre, C., Delcour, C., Hustinx, R., Luxen, A., Destee, A. & Salmon, E. 2013, “Multiclass classification of FDG PET scans for the distinction between Parkinson’s disease and atypical parkinsonian syndromes”, NeuroImage.Clinical, vol. 2, pp. 883-893. Gasca-Salas, C., Clavero, P., Garcia-Garcia, D., Obeso, J.A. & Rodriguez-Oroz, M.C. 2016, “Significance of visual
hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson’s disease patients with mild cognitive impairment”, Human brain mapping, vol. 37, no. 3, pp. 968-977.
Ge, J., Wu, P., Peng, S., Yu, H., Zhang, H., Guan, Y., Eidelberg, D., Zuo, C., Ma, Y. & Wang, J. 2015, “Assessing cerebral glucose metabolism in patients with idiopathic rapid eye movement sleep behavior disorder”,
Genovese, C.R., Lazar, N.A. & Nichols, T. 2002, “Thresholding of statistical maps in functional neuroimaging using the false discovery rate”, NeuroImage, vol. 15, no. 4, pp. 870-878.
Gilman, S., Koeppe, R.A., Chervin, R.D., Consens, F.B., Little, R., An, H., Junck, L. & Heumann, M. 2003, “REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA”, Neurology, vol. 61, no. 1, pp. 29-34.
Gonzalez-Redondo, R., Garcia-Garcia, D., Clavero, P., Gasca-Salas, C., Garcia-Eulate, R., Zubieta, J.L., Arbizu, J., Obeso, J.A. & Rodriguez-Oroz, M.C. 2014, “Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process”, Brain, vol. 137, no. Pt 8, pp. 2356-2367. Gratwicke, J., Jahanshahi, M. & Foltynie, T. 2015, “Parkinson’s disease dementia: a neural networks perspective”,
Brain, vol. 138, no. Pt 6, pp. 1454-1476.
Guttman, M., Boileau, I., Warsh, J., Saint-Cyr, J.A., Ginovart, N., McCluskey, T., Houle, S., Wilson, A., Mundo, E., Rusjan, P., Meyer, J. & Kish, S.J. 2007, “Brain serotonin transporter binding in non-depressed patients with Parkinson’s disease”, European journal of neurology, vol. 14, no. 5, pp. 523-528.
Habeck, C.G. 2010, “Basics of Multivariate Analysis in Neuroimaging Data”, J. Vis. Exp., vol. 41, no. e1988 10.3791/1988.
Habeck, C., Foster, N.L., Perneczky, R., Kurz, A., Alexopoulos, P., Koeppe, R.A., Drzezga, A. & Stern, Y. 2008, “Multivariate and univariate neuroimaging biomarkers of Alzheimer’s disease”, NeuroImage, vol. 40, no. 4, pp. 1503-1515.
Habeck, C., Krakauer, J.W., Ghez, C., Sackeim, H.A., Eidelberg, D., Stern, Y. & Moeller, J.R. 2005, “A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis”, Neural
computation, vol. 17, no. 7, pp. 1602-1645.
Habeck, C. & Moeller, J.R. 2011, “Intrinsic functional-connectivity networks for diagnosis: just beautiful pictures?”, Brain connectivity, vol. 1, no. 2, pp. 99-103.
Habeck, C., Stern, Y. & Alzheimer’s Disease Neuroimaging Initiative 2010, “Multivariate data analysis for neuroimaging data: overview and application to Alzheimer’s disease”, Cell biochemistry and biophysics, vol. 58, no. 2, pp. 53-67.
Hanyu, H., Inoue, Y., Sakurai, H., Kanetaka, H., Nakamura, M., Miyamoto, T., Sasai, T. & Iwamoto, T. 2012, “Voxel-based magnetic resonance imaging study of structural brain changes in patients with idiopathic REM sleep behavior disorder”, Parkinsonism & related disorders, vol. 18, no. 2, pp. 136-139.
Hanyu, H., Inoue, Y., Sakurai, H., Kanetaka, H., Nakamura, M., Miyamoto, T., Sasai, T. & Iwamoto, T. 2011, “Regional cerebral blood flow changes in patients with idiopathic REM sleep behavior disorder”, European
journal of neurology, vol. 18, no. 5, pp. 784-788.
Haugarvoll, K., Bindoff, L.A. & Tzoulis, C. 2016, “Nigrostriatal denervation sine parkinsonism”, Brain, vol. 139, no. Pt 4, pp. e25.
Heiss, W.D. 2014, “Cerebral Glucose Metabolism” in PET and SPECT of Neurobiological Systems, eds. R.A.J.O. Dierckx, A. Otte, E.F.J. de Vries, A. van Waarde & P.G.M. Luiten, Springer-Verlag Berlin Heidelberg, , pp. 85.
Heller, J., Brcina, N., Dogan, I., Holtbernd, F., Romanzetti, S., Schulz, J.B., Schiefer, J. & Reetz, K. 2016, “Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) - A systematic review on potential
biomarkers for neurodegeneration”, Sleep medicine reviews, .
Hellwig, S., Amtage, F., Kreft, A., Buchert, R., Winz, O.H., Vach, W., Spehl, T.S., Rijntjes, M., Hellwig, B., Weiller, C., Winkler, C., Weber, W.A., Tuscher, O. & Meyer, P.T. 2012, “(1)(8)F]FDG-PET is superior to [(1)(2)(3)I]IBZM-SPECT for the differential diagnosis of parkinsonism”, Neurology, vol. 79, no. 13, pp. 1314-1322.
Hely, M.A., Reid, W.G., Adena, M.A., Halliday, G.M. & Morris, J.G. 2008, “The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years”, Movement disorders, vol. 23, no. 6, pp. 837-844.
Herholz, K., Herscovitch, P. & Heiss, W. 2004, NeuroPET; PET in neuroscience and Clinical Neurology, Springer-Verlag Berlin Heidelberg, Germany.
Hernandez-Castillo, C.R., Diaz, R., Campos-Romo, A. & Fernandez-Ruiz, J. 2017, “Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease”, Cerebellum & ataxias, vol. 4, pp. 7-017-0065-7. eCollection 2017.
Hilker, R., Thomas, A.V., Klein, J.C., Weisenbach, S., Kalbe, E., Burghaus, L., Jacobs, A.H., Herholz, K. & Heiss, W.D. 2005, “Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways”, Neurology, vol. 65, no. 11, pp. 1716-1722.
Holtbernd, F., Gagnon, J.F., Postuma, R.B., Ma, Y., Tang, C.C., Feigin, A., Dhawan, V., Vendette, M., Soucy, J.P., Eidelberg, D. & Montplaisir, J. 2014, “Abnormal metabolic network activity in REM sleep behavior disorder”, Neurology, vol. 82, no. 7, pp. 620-627.
Holtbernd, F., Ma, Y., Peng, S., Schwartz, F., Timmermann, L., Kracht, L., Fink, G.R., Tang, C.C., Eidelberg, D. & Eggers, C. 2015, “Dopaminergic correlates of metabolic network activity in Parkinson’s disease”, Human
brain mapping, vol. 36, no. 9, pp. 3575-3585.
Hosokai, Y., Nishio, Y., Hirayama, K., Takeda, A., Ishioka, T., Sawada, Y., Suzuki, K., Itoyama, Y., Takahashi, S., Fukuda, H. & Mori, E. 2009, “Distinct patterns of regional cerebral glucose metabolism in Parkinson’s disease with and without mild cognitive impairment”, Movement disorders, vol. 24, no. 6, pp. 854-862. Huang, C., Mattis, P., Perrine, K., Brown, N., Dhawan, V. & Eidelberg, D. 2008, “Metabolic abnormalities
associated with mild cognitive impairment in Parkinson disease”, Neurology, vol. 70, no. 16 Pt 2, pp. 1470-1477.
Huang, C., Mattis, P., Tang, C., Perrine, K., Carbon, M. & Eidelberg, D. 2007, “Metabolic brain networks associated with cognitive function in Parkinson’s disease”, NeuroImage, vol. 34, no. 2, pp. 714-723. Huang, C., Ravdin, L.D., Nirenberg, M.J., Piboolnurak, P., Severt, L., Maniscalco, J.S., Solnes, L., Dorfman,
B.J. & Henchcliffe, C. 2013, “Neuroimaging markers of motor and nonmotor features of Parkinson’s disease: an 18f fluorodeoxyglucose positron emission computed tomography study”, Dementia and geriatric
cognitive disorders, vol. 35, no. 3-4, pp. 183-196.
Huang, C., Tang, C., Feigin, A., Lesser, M., Ma, Y., Pourfar, M., Dhawan, V. & Eidelberg, D. 2007, “Changes in network activity with the progression of Parkinson’s disease”, Brain, vol. 130, no. Pt 7, pp. 1834-1846. Huang, Z., Jiang, C., Li, L., Xu, Q., Ge, J., Li, M., Guan, Y., Wu, J., Wang, J., Zuo, C., Yu, H. & Wu, P. 2019,
“Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder”, Journal of cerebral blood flow and metabolism, pp. 271678X19828916.
Hughes, A.J., Daniel, S.E., Kilford, L. & Lees, A.J. 1992, “Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases”, Journal of neurology, neurosurgery, and psychiatry, vol. 55, no. 3, pp. 181-184.
Hummel, T., Sekinger, B., Wolf, S.R., Pauli, E. & Kobal, G. 1997, “’Sniffin’ sticks’: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold”, Chemical
senses, vol. 22, no. 1, pp. 39-52.
Huot, P. & Fox, S.H. 2013, “The serotonergic system in motor and non-motor manifestations of Parkinson’s disease”, Experimental brain research, vol. 230, no. 4, pp. 463-476.
Hyman, B.T., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Carrillo, M.C., Dickson, D.W., Duyckaerts, C., Frosch, M.P., Masliah, E., Mirra, S.S., Nelson, P.T., Schneider, J.A., Thal, D.R., Thies, B., Trojanowski, J.Q., Vinters, H.V. & Montine, T.J. 2012, “National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease”, Alzheimer’s & dementia, vol. 8, no. 1, pp. 1-13. Iranzo, A., Fernandez-Arcos, A., Tolosa, E., Serradell, M., Molinuevo, J.L., Valldeoriola, F., Gelpi, E., Vilaseca,
I., Sanchez-Valle, R., Llado, A., Gaig, C. & Santamaria, J. 2014, “Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients”, PloS one, vol. 9, no. 2, pp. e89741. Iranzo, A., Lomena, F., Stockner, H., Valldeoriola, F., Vilaseca, I., Salamero, M., Molinuevo, J.L., Serradell, M., Duch, J., Pavia, J., Gallego, J., Seppi, K., Hogl, B., Tolosa, E., Poewe, W., Santamaria, J. & Sleep Innsbruck Barcelona (SINBAR) group 2010, “Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected”, The Lancet Neurology, vol. 9, no. 11, pp. 1070-1077.
Iranzo, A., Santamaria, J., Pujol, J., Moreno, A., Deus, J. & Tolosa, E. 2002, “Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder”, Sleep, vol. 25, no. 8, pp. 867-870. Iranzo, A., Santamaria, J., Valldeoriola, F., Serradell, M., Salamero, M., Gaig, C., Ninerola-Baizan, A.,
Sanchez-Valle, R., Llado, A., De Marzi, R., Stefani, A., Seppi, K., Pavia, J., Hogl, B., Poewe, W., Tolosa, E. & Lomena, F. 2017, “Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder”, Annals of Neurology, vol. 82, no. 3, pp. 419-428. Iranzo, A., Serradell, M., Vilaseca, I., Valldeoriola, F., Salamero, M., Molina, C., Santamaria, J. & Tolosa, E.
2013a, “Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder”,
Parkinsonism & related disorders, vol. 19, no. 6, pp. 600-604.
Iranzo, A., Tolosa, E., Gelpi, E., Molinuevo, J.L., Valldeoriola, F., Serradell, M., Sanchez-Valle, R., Vilaseca, I., Lomena, F., Vilas, D., Llado, A., Gaig, C. & Santamaria, J. 2013b, “Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study”, Lancet neurology, vol. 12, no. 5, pp. 443-453.
Iranzo, A., Valldeoriola, F., Lomena, F., Molinuevo, J.L., Serradell, M., Salamero, M., Cot, A., Ros, D., Pavia, J., Santamaria, J. & Tolosa, E. 2011, “Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study”, The Lancet.
Neurology, vol. 10, no. 9, pp. 797-805.
Isaias, I.U., Marotta, G., Pezzoli, G., Sabri, O., Schwarz, J., Crenna, P., Classen, J. & Cavallari, P. 2011, “Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease”, BMC neurology, vol. 11, pp. 88-2377-11-88.
Isaias, I.U., Spiegel, J., Brumberg, J., Cosgrove, K.P., Marotta, G., Oishi, N., Higuchi, T., Kusters, S., Schiller, M., Dillmann, U., van Dyck, C.H., Buck, A., Herrmann, K., Schloegl, S., Volkmann, J., Lassmann, M., Fassbender, K., Lorenz, R. & Samnick, S. 2014, “Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson’s disease”, Frontiers in aging neuroscience, vol. 6, pp. 213. Ishibashi, K., Onishi, A., Fujiwara, Y., Oda, K., Ishiwata, K. & Ishii, K. 2018, “Longitudinal effects of aging
on (18)F-FDG distribution in cognitively normal elderly individuals”, Scientific reports, vol. 8, no. 1, pp. 11557-018-29937-y.
Janzen, J., van ‘t Ent, D., Lemstra, A.W., Berendse, H.W., Barkhof, F. & Foncke, E.M. 2012, “The
pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study”, Journal of neurology, vol. 259, no. 1, pp. 147-154.
Jellinger, K.A., Logroscino, G., Rizzo, G., Copetti, M., Arcuti, S., Martino, D. & Fontana, A. 2016, “Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis”, Neurology, vol. 87, no. 2, pp. 237-238.
Jenkinson, M., Bannister, P., Brady, M. & Smith, S. 2002, “Improved optimization for the robust and accurate linear registration and motion correction of brain images”, NeuroImage, vol. 17, no. 2, pp. 825-841. Jenkinson, M. & Smith, S. 2001, “A global optimisation method for robust affine registration of brain images”,
Medical image analysis, vol. 5, no. 2, pp. 143-156.
Joling, M., Vriend, C., van den Heuvel, O.A., Raijmakers, P.G.H.M., Jones, P.A., Berendse, H.W. & Booij, J. 2017, “Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases”, Journal of nuclear medicine, vol. 58, no. 7, pp. 1117-1123.
Jovalekic, A., Koglin, N., Mueller, A. & Stephens, A.W. 2017, “New protein deposition tracers in the pipeline”,
EJNMMI radiopharmacy and chemistry, vol. 1, no. 1, pp. 11-016-0015-3. Epub 2016 Jun 2.
Jueptner, M. & Weiller, C. 1995, “Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI”, NeuroImage, vol. 2, no. 2, pp. 148-156.
Juh, R., Kim, J., Moon, D., Choe, B. & Suh, T. 2004, “Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET”, European Journal of Radiology, vol. 51, no. 3, pp. 223-233.
Kaasinen, V., Maguire, R.P., Hundemer, H.P. & Leenders, K.L. 2006, “Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson’s disease”, Journal of neurology, vol. 253, no. 3, pp. 340-348.
Kadekaro, M., Crane, A.M. & Sokoloff, L. 1985, “Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat”, Proceedings of the National Academy of
Sciences of the United States of America, vol. 82, no. 17, pp. 6010-6013.
Karp, J.S., Surti, S., Daube-Witherspoon, M.E. & Muehllehner, G. 2008, “Benefit of time-of-flight in PET: experimental and clinical results”, Journal of nuclear medicine, vol. 49, no. 3, pp. 462-470.
Keren, N.I., Lozar, C.T., Harris, K.C., Morgan, P.S. & Eckert, M.A. 2009, “In vivo mapping of the human locus coeruleus”, NeuroImage, vol. 47, no. 4, pp. 1261-1267.
Kim, J.S., Park, H.E., Oh, Y.S., Lee, S.H., Park, J.W., Son, B.C. & Lee, K.S. 2016, “Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder”, Journal
Kim, Y.J., Ichise, M., Ballinger, J.R., Vines, D., Erami, S.S., Tatschida, T. & Lang, A.E. 2002, “Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP”,
Movement disorders, vol. 17, no. 2, pp. 303-312.
Kim, Y.K., Yoon, I.Y., Kim, J.M., Jeong, S.H., Kim, K.W., Shin, Y.K., Kim, B.S. & Kim, S.E. 2010, “The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder”, European journal of neurology, vol. 17, no. 3, pp. 487-492.
Klein, J.C., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., Vollmar, S., Baudrexel, S., Diederich, N.J., Heiss, W.D. & Hilker, R. 2010, “Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo”, Neurology, vol. 74, no. 11, pp. 885-892.
Klingelhoefer, L. & Reichmann, H. 2015, “Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors”, Nature reviews Neurology, vol. 11, no. 11, pp. 625-636.
Knudsen, G.M., Karlsborg, M., Thomsen, G., Krabbe, K., Regeur, L., Nygaard, T., Videbaek, C. & Werdelin, L. 2004, “Imaging of dopamine transporters and D2 receptors in patients with Parkinson’s disease and multiple system atrophy”, European journal of nuclear medicine and molecular imaging, vol. 31, no. 12, pp. 1631-1638.
Knudsen, K., Fedorova, T.D., Hansen, A.K., Sommerauer, M., Otto, M., Svendsen, K.B., Nahimi, A., Stokholm, M.G., Pavese, N., Beier, C.P., Brooks, D.J. & Borghammer, P. 2018, “In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study”, The Lancet.Neurology, vol. 17, no. 7, pp. 618-628.
Ko, J.H., Feigin, A., Mattis, P.J., Tang, C.C., Ma, Y., Dhawan, V., During, M.J., Kaplitt, M.G. & Eidelberg, D. 2014, “Network modulation following sham surgery in Parkinson’s disease”, The Journal of clinical
investigation, vol. 124, no. 8, pp. 3656-3666.
Ko, J.H., Lee, C.S. & Eidelberg, D. 2016, “Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations”, Journal of cerebral blood flow and metabolism, vol. 37, no.2, pp.683-693. Ko, J.H., Lerner, R.P. & Eidelberg, D. 2015, “Effects of levodopa on regional cerebral metabolism and blood
flow”, Movement disorders, vol. 30, no. 1, pp. 54-63.
Ko, J.H., Mure, H., Tang, C.C., Ma, Y., Dhawan, V., Spetsieris, P. & Eidelberg, D. 2013, “Parkinson’s disease: increased motor network activity in the absence of movement”, The Journal of neuroscience, vol. 33, no. 10, pp. 4540-4549.
Ko, J.H., Spetsieris, P.G. & Eidelberg, D. 2018, “Network Structure and Function in Parkinson’s Disease”,
Cerebral cortex, vol. 28, no. 12, pp. 4121-4135.
Kogan, R.V., de Jong, B.A., Renken, R.J., Meles, S.K., van Snick, P.J.H., Golla, S., Rijnsdorp, S., Perani, D., Leenders, K.L., Boellaard, R. & JPND-PETMETPAT Working Group 2019, “Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [(18)F]FDG-PET (PETMETPAT)”, Alzheimer’s & dementia, vol. 11, pp. 472-482.
Kortekaas, R., Eshuis, S.A., Andringa, G., Cools, A.R. & Leenders, K.L. 2013, “Motor behavior correlates with striatal [(1)(8)F]-DOPA uptake in MPTP-lesioned primates”, Neurochemistry international, vol. 62, no. 4, pp. 349-353.
Kotagal, V., Albin, R.L., Muller, M.L., Koeppe, R.A., Chervin, R.D., Frey, K.A. & Bohnen, N.I. 2012, “Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease”, Annals of Neurology, vol. 71, no. 4, pp. 560-568.
Kranz, G.S., Hahn, A., Savli, M. & Lanzenberger, R. 2012, “Challenges in the differentiation of midbrain raphe nuclei in neuroimaging research”, Proceedings of the National Academy of Sciences of the United States of
America, vol. 109, no. 29, E2000.
Kung, H.F., Alavi, A., Chang, W., Kung, M.P., Keyes, J.W.,Jr, Velchik, M.G., Billings, J., Pan, S., Noto, R. & Rausch 1990, “In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans”, Journal of nuclear medicine, vol. 31, no. 5, pp. 573-579.
Lecrux, C. & Hamel, E. 2016, “Neuronal networks and mediators of cortical neurovascular coupling responses in normal and altered brain states”, Philosophical transactions of the Royal Society of London.Series B, Biological
sciences, vol. 371, no. 1705, pp. 10.1098/rstb.2015.0350.
Lee, J.H., Han, Y.H., Cho, J.W., Lee, J.S., Lee, S.J., Kim, D.J., Kim, T.H., Kang, B.M., Kim, T.H. & Mun, C.W. 2014, “Evaluation of brain iron content in idiopathic REM sleep behavior disorder using quantitative magnetic resonance imaging”, Parkinsonism & related disorders, vol. 20, no. 7, pp. 776-778. Leenders, K.L., Salmon, E.P., Tyrrell, P., Perani, D., Brooks, D.J., Sager, H., Jones, T., Marsden, C.D. &
Frackowiak, R.S. 1990, “The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson’s disease”, Archives of Neurology, vol. 47, no. 12, pp. 1290-1298.
Lin, T.P., Carbon, M., Tang, C., Mogilner, A.Y., Sterio, D., Beric, A., Dhawan, V. & Eidelberg, D. 2008, “Metabolic correlates of subthalamic nucleus activity in Parkinson’s disease”, Brain, vol. 131, no. Pt 5, pp. 1373-1380.
Loos, C., Achten, E. & Santens, P. 2010, “Proton magnetic resonance spectroscopy in Alzheimer’s disease, a review”, Acta Neurologica Belgica, vol. 110, no. 4, pp. 291-298.
Lukas, C., Schols, L., Bellenberg, B., Rub, U., Przuntek, H., Schmid, G., Koster, O. & Suchan, B. 2006, “Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study”, Neuroscience letters, vol. 408, no. 3, pp. 230-235.
Lyoo, C.H., Jeong, Y., Ryu, Y.H., Rinne, J.O. & Lee, M.S. 2010, “Cerebral glucose metabolism of Parkinson’s disease patients with mild cognitive impairment”, European neurology, vol. 64, no. 2, pp. 65-73. Ma, Y., Tang, C., Moeller, J.R. & Eidelberg, D. 2009, “Abnormal regional brain function in Parkinson’s disease:
truth or fiction?”, NeuroImage, vol. 45, no. 2, pp. 260-266.
Ma, Y., Tang, C., Spetsieris, P.G., Dhawan, V. & Eidelberg, D. 2007, “Abnormal metabolic network activity in Parkinson’s disease: test-retest reproducibility”, Journal of cerebral blood flow and metabolism, vol. 27, no. 3, pp. 597-605.
Magistretti, P.J. & Allaman, I. 2015, “A cellular perspective on brain energy metabolism and functional imaging”,
Neuron, vol. 86, no. 4, pp. 883-901.
Mahlknecht, P., Iranzo, A., Hogl, B., Frauscher, B., Muller, C., Santamaria, J., Tolosa, E., Serradell, M., Mitterling, T., Gschliesser, V., Goebel, G., Brugger, F., Scherfler, C., Poewe, W., Seppi, K. & Sleep Innsbruck Barcelona Group 2015, “Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD”, Neurology, vol. 84, no. 7, pp. 654-658.
Mak, E., Su, L., Williams, G.B. & O’Brien, J.T. 2014, “Neuroimaging characteristics of dementia with Lewy bodies”, Alzheimer’s research & therapy, vol. 6, no. 2, pp. 18.
Manzanera, O.M., Meles, S.K., Leenders, K.L., Renken, R.J., Pagani, M., Arnaldi, D., Nobili, F., Obeso, J., Oroz, M.R., Morbelli, S. & Maurits, N.M. 2019, “Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson’s Disease in 3D Nuclear Imaging Data”, International journal
of neural systems, vol. 29, no. 09, 1950010.
Martin, W.R. 2007, “MR spectroscopy in neurodegenerative disease”, Molecular imaging and biology, vol. 9, no. 4, pp. 196-203.
Martin, W.R., Wieler, M. & Gee, M. 2008, “Midbrain iron content in early Parkinson disease: a potential biomarker of disease status”, Neurology, vol. 70, no. 16 Pt 2, pp. 1411-1417.
Matthews, D.C., Lerman, H., Lukic, A., Andrews, R.D., Mirelman, A., Wernick, M.N., Giladi, N., Strother, S.C., Evans, K.C., Cedarbaum, J.M. & Even-Sapir, E. 2018, “FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease”, NeuroImage.Clinical, vol. 20, pp. 572-579. Mattis, P.J., Niethammer, M., Sako, W., Tang, C.C., Nazem, A., Gordon, M.L., Brandt, V., Dhawan, V. &
Eidelberg, D. 2016, “Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases”, Neurology, vol. 87, no. 18, pp. 1925-1933.
Mattis, P.J., Tang, C.C., Ma, Y., Dhawan, V. & Eidelberg, D. 2011, “Network correlates of the cognitive response to levodopa in Parkinson disease”, Neurology, vol. 77, no. 9, pp. 858-865.
Mazere, J., Lamare, F., Allard, M., Fernandez, P. & Mayo, W. 2017, “123I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies”, Journal of nuclear medicine, vol. 58, no. 1, pp. 123-128.
Mazza, S., Soucy, J.P., Gravel, P., Michaud, M., Postuma, R., Massicotte-Marquez, J., Decary, A. & Montplaisir, J. 2006, “Assessing whole brain perfusion changes in patients with REM sleep behavior disorder”, Neurology, vol. 67, no. 9, pp. 1618-1622.
McKeith, I.G., Dickson, D.W., Lowe, J., Emre, M., O’Brien, J.T., Feldman, H., Cummings, J., Duda, J.E., Lippa, C., Perry, E.K., Aarsland, D., Arai, H., Ballard, C.G., Boeve, B., Burn, D.J., Costa, D., Del Ser, T., Dubois, B., Galasko, D., Gauthier, S., Goetz, C.G., Gomez-Tortosa, E., Halliday, G., Hansen, L.A., Hardy, J., Iwatsubo, T., Kalaria, R.N., Kaufer, D., Kenny, R.A., Korczyn, A., Kosaka, K., Lee, V.M., Lees, A., Litvan, I., Londos, E., Lopez, O.L., Minoshima, S., Mizuno, Y., Molina, J.A., Mukaetova-Ladinska, E.B., Pasquier, F., Perry, R.H., Schulz, J.B., Trojanowski, J.Q., Yamada, M. & Consortium on DLB 2005, “Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium”, Neurology, vol. 65, no. 12, pp. 1863-1872.
Meles, S.K., Kok, J.G., De Jong, B.M., Renken, R.J., de Vries, J.J., Spikman, J.M., Ziengs, A.L., Willemsen, A.T.M., van der Horn, H.J., Leenders, K.L. & Kremer, H.P.H. 2018a, “The cerebral metabolic topography of spinocerebellar ataxia type 3”, NeuroImage Clinical, vol. 19, pp. 90-97.
Meles, S.K., Renken, R.J., Janzen, A., Vadasz, D., Pagani, M., Arnaldi, D., Morbelli, S., Nobili, F., Mayer, G., Leenders, K.L. & Oertel, W.H.O. 2018b, “The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson’s disease”, Journal of nuclear medicine, vol. 59, no.9, pp 1437-1444. Meles, S.K., Tang, C.C., Teune, L.K., Dierckx, R.A., Dhawan, V., Mattis, P.J., Leenders, K.L. & Eidelberg,
D. 2015, “Abnormal metabolic pattern associated with cognitive impairment in Parkinson’s disease: a validation study”, Journal of cerebral blood flow and metabolism, vol. 35, no. 9, pp. 1478-1484.
Meles, S.K., Teune, L.K., de Jong, B.M., Dierckx, R.A. & Leenders, K.L. 2017a, “Metabolic Imaging in Parkinson Disease”, Journal of nuclear medicine, vol. 58, no. 1, pp. 23-28.
Meles, S.K., Vadasz, D., Renken, R.J., Sittig-Wiegand, E., Mayer, G., Depboylu, C., Reetz, K., Overeem, S., Pijpers, A., Reesink, F.E., van Laar, T., Heinen, L., Teune, L.K., Hoffken, H., Luster, M., Kesper, K., Adriaanse, S.M., Booij, J., Leenders, K.L. & Oertel, W.H. 2017b, “FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder”, Movement disorders, vol. 32, pp. 1482-1486.
Meyer, P.T., Frings, L., Rucker, G. & Hellwig, S. 2017, “(18)F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment”, Journal of nuclear medicine, vol. 58, no. 12, pp. 1888-1898. Minoshima, S., Frey, K.A., Koeppe, R.A., Foster, N.L. & Kuhl, D.E. 1995, “A diagnostic approach in Alzheimer’s
disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET”, Journal of
nuclear medicine, vol. 36, no. 7, pp. 1238-1248.
Moeller, J.R. & Eidelberg, D. 1997, “Divergent expression of regional metabolic topographies in Parkinson’s disease and normal ageing”, Brain, vol. 120, Pt 12, pp. 2197-2206.
Moeller, J.R. & Habeck, C.G. 2006, “Reciprocal Benefits of Mass-Univariate and Multivariate Modeling in Brain Mapping: Applications to Event-Related Functional MRI, H(2) (15)O-, and FDG-PET”, International
journal of biomedical imaging, vol. 2006, pp. 79862.
Moeller, J.R., Ishikawa, T., Dhawan, V., Spetsieris, P., Mandel, F., Alexander, G.E., Grady, C., Pietrini, P. & Eidelberg, D. 1996, “The metabolic topography of normal aging”, Journal of cerebral blood flow and
metabolism, vol. 16, no. 3, pp. 385-398.
Moeller, J.R. & Strother, S.C. 1991, “A regional covariance approach to the analysis of functional patterns in positron emission tomographic data”, Journal of cerebral blood flow and metabolism, vol. 11, no. 2, pp. A121-35.
Moeller, J.R., Strother, S.C., Sidtis, J.J. & Rottenberg, D.A. 1987, “Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data”, Journal of cerebral blood flow
and metabolism, vol. 7, no. 5, pp. 649-658.
Morbelli, S., Garibotto, V., Van De Giessen, E., Arbizu, J., Chetelat, G., Drezgza, A., Hesse, S., Lammertsma, A.A., Law, I., Pappata’, S., Payoux, P., Pagani, M. & European Association of Nuclear Medicine 2015, “A Cochrane review on brain [(1)(8)F]FDG PET in dementia: limitations and future perspectives”, European
journal of nuclear medicine and molecular imaging, vol. 42, no. 10, pp. 1487-1491.
Morbelli, S., Perneczky, R., Drzezga, A., Frisoni, G.B., Caroli, A., van Berckel, B.N., Ossenkoppele, R., Guedj, E., Didic, M., Brugnolo, A., Naseri, M., Sambuceti, G., Pagani, M. & Nobili, F. 2013, “Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project”, Journal of nuclear medicine, vol. 54, no. 6, pp. 894-902.
Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease 2003, “The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations”, Movement disorders, vol. 18, no. 7, pp. 738-750.
Mudali, D., Biehl, M., Meles, S.K., Renken, R.J., Garcia-Garcia, D., Clavero, P., Arbizu, J., Obeso, J.A., Rodriguez-Oroz, M.C., Leenders, K.L. & Roerdink, J.B.T.M. 2016, “Differentiating Early and Late Stage Parkinson’s Disease from Healthy Controls”, Journal of Biomedical Engineering and Medical Imaging, vol. 3(6), pp. 33-43.
Mudali, D., Teune, L.K., Renken, R.J., Leenders, K.L. & Roerdink, J.B. 2015, “Classification of Parkinsonian syndromes from FDG-PET brain data using decision trees with SSM/PCA features”, Computational and
mathematical methods in medicine, vol. 2015, 136921.
Mure, H., Hirano, S., Tang, C.C., Isaias, I.U., Antonini, A., Ma, Y., Dhawan, V. & Eidelberg, D. 2011, “Parkinson’s disease tremor-related metabolic network: characterization, progression, and treatment effects”,
NeuroImage, vol. 54, no. 2, pp. 1244-1253.
Muslimovic, D., Post, B., Speelman, J.D., De Haan, R.J. & Schmand, B. 2009, “Cognitive decline in Parkinson’s disease: a prospective longitudinal study”, Journal of the International Neuropsychological Society, vol. 15, no. 3, pp. 426-437.
Niethammer, M., Tang, C.C., Feigin, A., Allen, P.J., Heinen, L., Hellwig, S., Amtage, F., Poston, K.L., Hanspal, E., Vonsattel, J.P., Meyer, P.T., Leenders, K.L. & Eidelberg, D.E. 2014, “A Disease-Specific Metabolic Brain Network Associated with Corticobasal Degeneration”, Brain, vol. 137, no. 11, pp. 3036–3046.
Niethammer, M. & Eidelberg, D. 2012, “Metabolic brain networks in translational neurology: Concepts and Applications”, Annals of Neurology, vol. 72, no. 5, pp. 635-647.
Niethammer, M., Tang, C.C., Ma, Y., Mattis, P.J., Ko, J.H., Dhawan, V. & Eidelberg, D. 2013, “Parkinson’s disease cognitive network correlates with caudate dopamine”, NeuroImage, vol. 78, pp. 204-209. Nirenberg, M.J., Vaughan, R.A., Uhl, G.R., Kuhar, M.J. & Pickel, V.M. 1996, “The dopamine transporter is
localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons”, The Journal of
neuroscience, vol. 16, no. 2, pp. 436-447.
Nobili, F., Festari, C., Altomare, D., Agosta, F., Orini, S., Van Laere, K., Arbizu, J., Bouwman, F., Drzezga, A., Nestor, P., Walker, Z., Boccardi, M. & EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders 2018, “Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders”, European journal of nuclear medicine and molecular
imaging, vol. 45, no. 9, pp. 1557-1566.
Nomura, T., Inoue, Y., Hogl, B., Uemura, Y., Kitayama, M., Abe, T., Miyoshi, H. & Nakashima, K. 2010, “Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson’s disease”,
Parkinsonism & related disorders, vol. 16, no. 10, pp. 683-685.
Oswal, A., Brown, P. & Litvak, V. 2013, “Synchronized neural oscillations and the pathophysiology of Parkinson’s disease”, Current opinion in neurology, vol. 26, no. 6, pp. 662-670.
O’Toole, A.J., Jiang, F., Abdi, H., Penard, N., Dunlop, J.P. & Parent, M.A. 2007, “Theoretical, statistical, and practical perspectives on pattern-based classification approaches to the analysis of functional neuroimaging data”, Journal of cognitive neuroscience, vol. 19, no. 11, pp. 1735-1752.
Pagani, M., Giuliani, A., Oberg, J., Chincarini, A., Morbelli, S., Brugnolo, A., Arnaldi, D., Picco, A., Bauckneht, M., Buschiazzo, A., Sambuceti, G. & Nobili, F. 2016, “Predicting the transition from normal aging to Alzheimer’s disease: A statistical mechanistic evaluation of FDG-PET data”, NeuroImage, vol. 141, pp. 282-290.
Pagani, M.M., Giuliani, A., Oberg, J., De Carli, F., Morbelli, S., Girtler, N., Bongioanni, F., Arnaldi, D., Accardo, J., Bauckneht, M., Chincarini, A., Sambuceti, G., Jonsson, C. & Nobili, F. 2017, “Progressive disgregation of brain networking from normal aging to Alzhimer’s Disease. Independent Component Analysis on FDG-PET data”, Journal of nuclear medicine, vol. 58, no. 7, pp. 1132-1139.
Palop, J.J., Chin, J. & Mucke, L. 2006, “A network dysfunction perspective on neurodegenerative diseases”,
Nature, vol. 443, no. 7113, pp. 768-773.
Pandya, S.Y., Clem, M.A., Silva, L.M. & Woon, F.L. 2016, “Does mild cognitive impairment always lead to dementia? A review”, Journal of the neurological sciences, vol. 369, pp. 57-62.
Pappata, S., Santangelo, G., Aarsland, D., Vicidomini, C., Longo, K., Bronnick, K., Amboni, M., Erro, R., Vitale, C., Caprio, M.G., Pellecchia, M.T., Brunetti, A., De Michele, G., Salvatore, M. & Barone, P. 2011, “Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism”,
Neurology, vol. 77, no. 14, pp. 1357-1362.
Pavese, N., Rivero-Bosch, M., Lewis, S.J., Whone, A.L. & Brooks, D.J. 2011, “Progression of monoaminergic dysfunction in Parkinson’s disease: a longitudinal 18F-dopa PET study”, NeuroImage, vol. 56, no. 3, pp. 1463-1468.
Pavese, N., Simpson, B.S., Metta, V., Ramlackhansingh, A., Chaudhuri, K.R. & Brooks, D.J. 2012, “(1)(8)F] FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [(1)(8) F]FDOPA and [(1)(1)C]DASB PET study in Parkinson’s disease”, NeuroImage, vol. 59, no. 2, pp. 1080-1084.
Pedroso, J.L., Franca, M.C.,Jr, Braga-Neto, P., D’Abreu, A., Saraiva-Pereira, M.L., Saute, J.A., Teive, H.A., Caramelli, P., Jardim, L.B., Lopes-Cendes, I. & Barsottini, O.G. 2013, “Nonmotor and extracerebellar features in Machado-Joseph disease: a review”, Movement disorders, vol. 28, no. 9, pp. 1200-1208. Peever, J., Luppi, P.H. & Montplaisir, J. 2014, “Breakdown in REM sleep circuitry underlies REM sleep behavior
disorder”, Trends in neurosciences, vol. 37, no. 5, pp. 279-288.
Peng, S., Eidelberg, D. & Ma, Y. 2014, “Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease”, Neuroscience bulletin, vol. 30, no. 5, pp. 823-837.
Perani, D., Cerami, C., Caminiti, S.P., Santangelo, R., Coppi, E., Ferrari, L., Pinto, P., Passerini, G., Falini, A., Iannaccone, S., Cappa, S.F., Comi, G., Gianolli, L. & Magnani, G. 2016, “Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting”, European journal of
nuclear medicine and molecular imaging, vol. 43, no. 3, pp. 499-508.
Perani, D., Schillaci, O., Padovani, A., Nobili, F.M., Iaccarino, L., Della Rosa, P.A., Frisoni, G. & Caltagirone, C. 2014, “A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis”, BioMed research
international, vol. 2014, pp. 785039.
Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos, E.G. & Kokmen, E. 1999, “Mild cognitive impairment: clinical characterization and outcome”, Archives of Neurology, vol. 56, no. 3, pp. 303-308. Phelps, M.E., Hoffman, E.J., Huang, S.C. & Ter-Pogossian, M.M. 1975, “Effect of positron range on spatial
resolution”, Journal of nuclear medicine, vol. 16, no. 7, pp. 649-652.
Phillips, A.A., Chan, F.H., Zheng, M.M., Krassioukov, A.V. & Ainslie, P.N. 2016, “Neurovascular coupling in humans: Physiology, methodological advances and clinical implications”, Journal of cerebral blood flow and
metabolism, vol. 36, no. 4, pp. 647-664.
Ponsen, M.M., Stoffers, D., Booij, J., van Eck-Smit, B.L., Wolters, E.C. & Berendse, H.W. 2004, “Idiopathic hyposmia as a preclinical sign of Parkinson’s disease”, Annals of Neurology, vol. 56, no. 2, pp. 173-181.
Poston, K.L., Tang, C.C., Eckert, T., Dhawan, V., Frucht, S., Vonsattel, J.P., Fahn, S. & Eidelberg, D. 2012, “Network correlates of disease severity in multiple system atrophy”, Neurology, vol. 78, no. 16, pp. 1237-1244.
Postuma, R.B., Berg, D., Stern, M., Poewe, W., Olanow, C.W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A.E., Halliday, G., Goetz, C.G., Gasser, T., Dubois, B., Chan, P., Bloem, B.R., Adler, C.H. & Deuschl, G. 2015, “MDS clinical diagnostic criteria for Parkinson’s disease”, Movement disorders, vol. 30, no. 12, pp. 1591-1601.
Postuma, R.B., Gagnon, J.F., Vendette, M., Fantini, M.L., Massicotte-Marquez, J. & Montplaisir, J. 2009, “Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder”, Neurology, vol. 72, no. 15, pp. 1296-1300.
Postuma, R.B., Iranzo, A., Hogl, B., Arnulf, I., Ferini-Strambi, L., Manni, R., Miyamoto, T., Oertel, W., Dauvilliers, Y., Ju, Y.E., Puligheddu, M., Sonka, K., Pelletier, A., Santamaria, J., Frauscher, B., Leu-Semenescu, S., Zucconi, M., Terzaghi, M., Miyamoto, M., Unger, M.M., Carlander, B., Fantini, M.L. & Montplaisir, J.Y. 2015, “Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study”, Annals of Neurology, vol. 77, no. 5, pp. 830-839.
Postuma, R.B., Lang, A.E., Gagnon, J.F., Pelletier, A. & Montplaisir, J.Y. 2012, “How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder”, Brain, vol. 135, no. Pt 6, pp. 1860-1870.
Pyatigorskaya, N., Gaurav, R., Arnaldi, D., Leu-Semenescu, D., Yahia-Cherif, L., Valabregue, R., Vidailhet, M., Arnulf, I. & Lehéricy, S. 2017, “MRI biomarkers to assess substantia nigra damage in idiopathic REM sleep behavior disorder”, Sleep, vol 40, no.11, zsx149.
Rahayel, S., Montplaisir, J., Monchi, O., Bedetti, C., Postuma, R.B., Brambati, S., Carrier, J., Joubert, S., Latreille, V., Jubault, T. & Gagnon, J.F. 2015, “Patterns of cortical thinning in idiopathic rapid eye movement sleep behavior disorder”, Movement disorders, vol. 30, no. 5, pp. 680-687.
Raichle, M.E., Larson, K.B., Phelps, M.E., Grubb, R.L.,Jr, welch, M.J. & Ter-Pogossian, M.M. 1975, “In vivo measurement of brain glucose transport and metabolism employing glucose-11C”, The American Journal of
Physiology, vol. 228, no. 6, pp. 1936-1948.
Reetz, K., Costa, A.S., Mirzazade, S., Lehmann, A., Juzek, A., Rakowicz, M., Boguslawska, R., Schols, L., Linnemann, C., Mariotti, C., Grisoli, M., Durr, A., van de Warrenburg, B.P., Timmann, D., Pandolfo, M., Bauer, P., Jacobi, H., Hauser, T.K., Klockgether, T., Schulz, J.B. & axia Study Group Investigators 2013, “Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6”, Brain, vol. 136, no. Pt 3, pp. 905-917.
Reijneveld, J.C., Ponten, S.C., Berendse, H.W. & Stam, C.J. 2007, “The application of graph theoretical analysis to complex networks in the brain”, Clinical neurophysiology, vol. 118, no. 11, pp. 2317-2331.
Reivich, M., Kuhl, D., Wolf, A., Greenberg, J., Phelps, M., Ido, T., Casella, V., Fowler, J., Hoffman, E., Alavi, A., Som, P. & Sokoloff, L. 1979, “The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man”, Circulation research, vol. 44, no. 1, pp. 127-137.
Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. 2005, “Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system”, Brain, vol. 128, no. Pt 6, pp. 1314-1322.
